Variations in Porphobilinogen and 5-Aminolevulinic Acid Concentrations in Plasma and Urine from Asymptomatic Carriers of the Acute Intermittent Porphyria Gene with Increased Porphyrin Precursor Excretion
Open Access
- 1 April 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (4), 701-707
- https://doi.org/10.1373/clinchem.2005.058198
Abstract
Background: The heme precursors porphobilinogen (PBG) and 5-aminolevulinic acid (ALA) accumulate during overt crises of acute intermittent porphyria (AIP), and high excretion of these metabolites often continues in the asymptomatic phase. Methods: We measured concentrations of PBG and ALA and investigated the correlation between these metabolites in plasma and urine in 10 asymptomatic AIP carriers with high excretion and in 5 healthy individuals. We quantified plasma concentrations with an HPLC–mass spectrometric method and urine concentrations with ion-exchange chromatography. Results: The mean (SD) plasma concentrations of PBG and ALA in the AIP carriers were 3.1 (1.0) and 1.7 (0.7) μmol/L, respectively. The mean 8-h urinary excretion amounts of PBG and ALA in the AIP carriers were 102 (25) and 56 (18) μmol, respectively, whereas the corresponding values for healthy individuals were 2.9 (0.7) and 9.3 (1.2) μmol. The correlations between PBG and ALA values in plasma and urine of the AIP carriers were 0.678 and 0.856, respectively. The mean PBG/ALA ratio was ∼2.0 in both plasma and urine for the AIP carriers and 0.3 in urine for the healthy individuals. The renal clearance rates for PBG and ALA were 71 (15) and 70 (13) mL/min, respectively. Conclusions: The described HPLC-mass spectrometric method enabled characterization of variations in plasma PBG and ALA in AIP carriers during an 8-h period. The renal clearances were similar for both metabolites. This method could be used to monitor AIP patients during treatment.Keywords
This publication has 13 references indexed in Scilit:
- Clinical and Biochemical Characteristics and Genotype-Phenotype Correlation in 143 Finnish and Russian Patients With Acute Intermittent PorphyriaMedicine, 2005
- Liquid chromatography–tandem mass spectrometry method for the simultaneous determination of δ-ALA, tyrosine and creatinine in biological fluidsClinica Chimica Acta; International Journal of Clinical Chemistry, 2004
- Fluorometric measurement of 5-aminolevulinic acid in serumClinica Chimica Acta; International Journal of Clinical Chemistry, 2004
- Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase geneClinical Genetics, 2002
- Capillary zone electrophoresis/mass spectrometry of 5-aminolaevulinic acid and porphobilinogenRapid Communications in Mass Spectrometry, 2000
- Porphyrins, porphyrin metabolism and porphyrias. I. UpdateScandinavian Journal of Clinical and Laboratory Investigation, 2000
- Porphyrins, porphyrin metabolism and porphyrias. II. Diagnosis and monitoring in the acute porphyriasScandinavian Journal of Clinical and Laboratory Investigation, 2000
- δ-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: Studies in normal, uraemic and porphyric subjectsClinical Science, 1987
- Urinary Delta-Aminolevulinic Acid (ALA) Levels in Lead PoisoningArchives of environmental health, 1967
- THE OCCURRENCE AND DETERMINATION OF δ-AMINOLEVULINIC ACID AND PORPHOBILINOGEN IN URINEOnline Journal of Public Health Informatics, 1956